Currently predicting for Thu, 4 Jun 2026

ZYME Prediction Chart

ZYME Predictions History

Latest community submissions for ZYME.
Predictor Target Session Target Price Result Direction Accuracy Score
Alan Alan Pro @Alan.115878
Sep 16, 2019 $25.36 -1.82% $25.83 X 98.18% 0
Alan Alan Pro @Alan.115878
Sep 12, 2019 $27.53 +5.72% $26.04 X 94.28% 0
Alan Alan Pro @Alan.115878
Sep 11, 2019 $26.49 +0.11% $26.46 X 99.89% 5
Alan Alan Pro @Alan.115878
Sep 10, 2019 $28.38 +5.19% $26.98 X 94.81% 1
JS JS Pro
Aug 27, 2019 $24.62 -1.60% $25.02 X 98.40% 0
Apr 29, 2019 $17.30 -5.36% $18.28 X 94.64% 0
Apr 24, 2019 $15.84 -6.05% $16.86 X 93.95% 0
Apr 23, 2019 $15.59 -7.20% $16.80 X 92.80% 0
JS JS Pro
Jan 30, 2019 $14.95 -3.42% $15.48 X 96.60% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ZYME with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ZYMEWORKS INC
Zymeworks
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE